Literature DB >> 2827824

Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.

D M Aked1, S J Foster.   

Abstract

1. Acute inflammation was induced in rabbit skin by intradermal injection of arachidonic acid. 2. Inflammation was assessed by the local accumulation of intravenously-injected 125I-serum albumin (plasma extravasation) and histologically (polymorphonuclear leucocyte, PMNL infiltration). 3. Leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) were extracted from skin and fractionated using C18 mini-columns. They were quantitated by specific radioimmunoassays and authenticated by reversed-phase high performance liquid chromatography analysis. 4. Maximally elevated levels of LTB4 and PGE2 were detected in skin 5 min after arachidonic acid injection. At subsequent times the eicosanoid content of the skin decreased. 5. The decrease in the eicosanoid content of the skin was due to rapid clearance (t 1/2 approximately 5 min) via the microvasculature and not a consequence of metabolism. 6. The concentration of LTB4 and PGE2 measured in inflamed skin was sufficient to account for the plasma extravasation and PMNL infiltration induced by arachidonic acid. The model therefore is useful for evaluating the anti-inflammatory efficacy of inhibitors of arachidonic acid metabolism including 5-lipoxygenase inhibitors. 7. The consequences of the rapid clearance of LTB4 from inflammatory sites are discussed with respect to its measurement in inflammatory disease and its role as an acute inflammatory mediator.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827824      PMCID: PMC1853695          DOI: 10.1111/j.1476-5381.1987.tb11355.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

2.  Leukotriene B4: an inflammatory mediator in vivo.

Authors:  M A Bray; A W Ford-Hutchinson; M J Smith
Journal:  Prostaglandins       Date:  1981-08

3.  Radioimmunoassay of LTB4 and 6-trans LTB4: analytical and pharmacological characterisation of immunoreactive LTB4 in ionophore stimulated human blood.

Authors:  F Carey; R A Forder
Journal:  Prostaglandins Leukot Med       Date:  1986-04

4.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

5.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

6.  Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.

Authors:  W S Powell
Journal:  Prostaglandins       Date:  1980-11

7.  The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin.

Authors:  G A Higgs; J A Salmon; J A Spayne
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

8.  Leukotriene B4: a mediator of vascular permeability.

Authors:  M A Bray; F M Cunningham; A W Ford-Hutchinson; M J Smith
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

9.  Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.

Authors:  R P Carlson; L O'Neill-Davis; J Chang; A J Lewis
Journal:  Agents Actions       Date:  1985-12

10.  Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.

Authors:  S E Dahlén; J Björk; P Hedqvist; K E Arfors; S Hammarström; J A Lindgren; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  11 in total

1.  FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.

Authors:  A Blackham; R J Griffiths; C Hallam; J Mann; P D Mitchell; A A Norris; W T Simpson
Journal:  Agents Actions       Date:  1990-06

2.  2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.

Authors:  S J Foster; P Bruneau; E R Walker; R M McMillan
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.

Authors:  N Ohmi; C Tani; K Yamada; M Fukui
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

4.  Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

Review 5.  Leukotriene B4 and inflammatory disease.

Authors:  R M McMillan; S J Foster
Journal:  Agents Actions       Date:  1988-06

6.  Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.

Authors:  D J Fretland; D L Widomski; J M Zemaitis; S W Djurić; R L Shone
Journal:  Inflammation       Date:  1989-10       Impact factor: 4.092

7.  Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.

Authors:  P G Hellewell; P J Jose; T J Williams
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits.

Authors:  S Marleau; N Dallaire; P E Poubelle; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Inflammation of guinea pig dermis. Effects of leukotriene B4 receptor antagonist, SC-41930.

Authors:  D J Fretland; D L Widomski; J M Zemaitis; R E Walsh; S Levin; S W Djuric; R L Shone; B S Tsai; T S Gaginella
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

10.  Selective chiral inhibitors of 5-lipoxygenase with anti-inflammatory activity.

Authors:  R M McMillan; J M Girodeau; S J Foster
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.